BACKGROUND: Several tests may be used to assess exercise intolerance in cystic fibrosis (CF), including the gold standard cardiopulmonary exercise test (CPET) and the Modified Shuttle Test (MST). OBJECTIVE: To evaluate the use of the MST as a predictor of peak oxygen uptake (VO2 peak) and to compare VO2 peak and maximal heart rate (HRmax) obtained in both tests. METHODS: Cross-sectional study including individuals with CF aged between 6 and 20 years old. Participants who were unable to perform the tests and/or presented signs of pulmonary exacerbation were excluded. Demographic, anthropometric, clinical and spirometric values were collected. CPET and the MST were performed in two consecutive outpatient visits. HRmax, peripheral oxygen saturation, dyspnea, and VO2 peak measured and estimated were compared. RESULTS: Twenty-four patients, mean age 15.7 ± 4.2 years and FEV1 (% predicted) 76.4 ± 23.8, were included. Mean values of HRmax (bpm) and HRmax in percent of predicted (HRmax%) were lower (P = 0.01) in the MST (171.6 ± 14.5 and 87.1 ± 7.5) compared to CPET (180.9 ± 10.0 and 91.9 ± 5.4). However, there was no significant differences between tests in the variation (delta) for HRmax and HRmax% (P = 0.17). A strong correlation (r = 0.79; P < 0.0001) was found between distance achieved (MST) and VO2 peak (CPET). The regression model to estimate VO2 peak resulted in the following equation: VO2 (mL · kg-1 · min-1 ) = 20.301 + 0.019 × MST distance (meters). There was no difference (P = 0.50) between VO2 peak measured (CPET) and estimated by the equation. CONCLUSION: The MST may be an alternative method to evaluate exercise capacity and to predict VO2 peak in children and adolescents with CF.
BACKGROUND: Several tests may be used to assess exercise intolerance in cystic fibrosis (CF), including the gold standard cardiopulmonary exercise test (CPET) and the Modified Shuttle Test (MST). OBJECTIVE: To evaluate the use of the MST as a predictor of peak oxygen uptake (VO2 peak) and to compare VO2 peak and maximal heart rate (HRmax) obtained in both tests. METHODS: Cross-sectional study including individuals with CF aged between 6 and 20 years old. Participants who were unable to perform the tests and/or presented signs of pulmonary exacerbation were excluded. Demographic, anthropometric, clinical and spirometric values were collected. CPET and the MST were performed in two consecutive outpatient visits. HRmax, peripheral oxygen saturation, dyspnea, and VO2 peak measured and estimated were compared. RESULTS: Twenty-four patients, mean age 15.7 ± 4.2 years and FEV1 (% predicted) 76.4 ± 23.8, were included. Mean values of HRmax (bpm) and HRmax in percent of predicted (HRmax%) were lower (P = 0.01) in the MST (171.6 ± 14.5 and 87.1 ± 7.5) compared to CPET (180.9 ± 10.0 and 91.9 ± 5.4). However, there was no significant differences between tests in the variation (delta) for HRmax and HRmax% (P = 0.17). A strong correlation (r = 0.79; P < 0.0001) was found between distance achieved (MST) and VO2 peak (CPET). The regression model to estimate VO2 peak resulted in the following equation: VO2 (mL · kg-1 · min-1 ) = 20.301 + 0.019 × MST distance (meters). There was no difference (P = 0.50) between VO2 peak measured (CPET) and estimated by the equation. CONCLUSION: The MST may be an alternative method to evaluate exercise capacity and to predict VO2 peak in children and adolescents with CF.
Authors: Pitiguara de Freitas Coelho; Roberta Ribeiro Batista Barbosa; Rodrigo Dos Santos Lugao; Fernanda Mayrink Gonçalves Liberato; Pâmela Reis Vidal; Roberta de Cássia Nunes Cruz Melotti; Márcio Vinícius Fagundes Donadio Journal: Hong Kong Physiother J Date: 2021-06-11